Cagrilintide Description
Cagrilintide is a novel long-acting amylin analogue featuring N-terminal lipidation that extends its half-life by binding to albumin. This synthetic peptide mimics and enhances natural amylin’s effects, simultaneously targeting multiple metabolic and appetite regulation pathways in both homeostatic and hedonic systems.
Cagrilintide Peptide Structure
Sequence: XKCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP
Molecular Formula: C194H312N54O59S2
Molecular Weight: 4409 g/mol
PubChem CID: 171397054
Synonyms:
- 1415456-99-3
- Cagrilintide [INN]
- AO43BIF1U8
- LDERDVMBIYGIOI-IZVMHKDJSA-N
Research Areas:
- Weight Management
- Glycemic Control
- Cardiovascular Health
Source: PubChem
Lyophilized Peptides:
Our cagrilintide is provided as a lyophilized (freeze-dried) powder. This process extends shelf life and preserves the purity and integrity of the peptide without the use of any fillers.